肿瘤患者化疗常见并发症预警管理的研究进展
摘要
对肿瘤患者化疗常见并发症进行介绍,分析其对患者的影响,重点阐述国内外肿瘤患者化疗常见并发症预警管理的研究现状,为构建适合我国国情的肿瘤患者化疗常见并发症预警系统提供参考依据。
引文
[1] 金珊,谭诗生,蒋莹,等.鸦胆子油乳注射液治疗晚期恶性肿瘤60例临床观察[J].贵州医药,2015,39(08):726-727.
[2] 郝希山.中国恶性肿瘤流行趋势及预防[C].第十三届中国科协年会第18分会场——癌症流行趋势和防控策略研究研讨会论文集.2011:10-11.
[3] 吴菲,林国桢,张晋昕.我国恶性肿瘤发病现状及趋势[J].中国肿瘤,2012,21(02):81-85.
[4] Torre L A,Bray F,Siegel R L,et al.Global cancer statistics,2012[J].CA:A Cancer J Clin,2015,65(2):87-108.
[5] Mcguire S.World Cancer Report 2014-Geneva,Switzerland:World Health Organization,International Agency for Research on Cancer,WHO Press,2015[J].Adv Nutr,2016,7(2):418-419.
[6] 陈万青,郑荣寿,张思维,等.2013年中国恶性肿瘤发病和死亡分析[J].中国肿瘤,2017,26(1):1-7.
[7] 中华人民共和国国家统计局.中国统计年鉴2016[M].北京:中国统计出版社,2016:1123-1124.
[8] 井明晰,于绍芬,段博识.肿瘤内科患者治疗中常见并发症的观察与处理对策[J].中国卫生产业,2012(14):162-162.
[9] Gupta V,Liu Y.New Insights on Glucosylceramide Synthase in Cancer Drug Resistance and Myelosuppression[J].Biochem Pharmacol,2013,2(03):120-123.
[10] Grnberg B H,Sundstrm S,Kaasa S,et al.Influence of comorbidity on survival,toxicity and health-related quality of life in patients with advanced non-small-cell lung cancer receiving platinum-doublet chemotherapy[J].Europ J Cancer,2010,46(12):2225-2234.
[11] Ballatori E,Roila F,Ruggeri B,et al.The impact of chemotherapy-induced nausea and vomiting on health-related quality of life.[J].Support Care Cancer,2007,15(2):179-185.
[12] Fujitani K,Ajani J A,Crane C H,et a1.Impact of induction chemothearpy and peropeartive chemoadriothearpy on opeartive morbidity and moartlity inpatients with loeoergional adencoacrinma of the stomach or gastroesphageal junction[J].Ann Surg Oncol,2007,14(7):2010-2017.
[13] Mrugank B P,Hareesha R P.Prospective Observational,Non-Randomized,Parallel Sequence study for assessment of Adverse Drug Reactions due to Chemo-therapeutic treatment in different types of Cancer patients[J].IJPSR,2013,4(1):386-391.
[14] 郑梦颖.化疗药物不良反应的临床表现及研究进展[D].重庆:重庆医科大学,2012.
[15] Chopra D,Rehan H S,Sharma V,et al.Chemotherapy-induced adverse drug reactions in oncology patients:A prospective observational survey[J].Indian J Med Paediatr Oncol,2016,37(1):42-46.
[16] 张阳,田丽,陈长英.化疗致脱发对癌症病人治疗依从性的影响及护理进展[J].护理研究,2017,31(29):3643-3646.
[17] Extermann M,Boler I,Reich RR,et al.Predicting the risk of chemotherapy toxicity in older patients:the Chemotherapy Risk Assessment Scale for High-Age Patients ( CRASH )score[J].Cancer,2012,118(13):3377-3386.
[18] Aapro M,Carides A,Rapoport BL,et al.Aprepitant and fosa-prepitant:A 10-year review of efficacy and safety[J].Oncologist,2015,20(4):450-458.
[19] Kearney N,Miller M,Maguire R,et al.WISECARE plus:Results of a European study of a nursing intervention for the management of chemotherapy-related symptoms[J].Eur J Oncol Nurs,2008,12(5):443-448.
[20] 王亚楠.新型抗肿瘤药物不良反应调查分析[D].济南:山东大学,2014.
[21] Lucas D,Scheiermann C,Chow A,et al.Chemotherapy-induced bone marrow nerve injury impairs hematopoietic regeneration[J].Nature Medicine,2013,19(6):695-703.
[22] 周婉,许勤,言克莉,等.消化道肿瘤化疗患者营养状况与生活质量及化疗不良反应的相关性分析[J].护理学报,2015,22(09):1-4.
[23] 王晓辉,朱珺,赵东.肺癌化疗不良反应的经济学研究[J].上海交通大学学报(医学版),2012,32(5):657-660.
[24] Nuckols TK,Paddock SM,Bower AG,et al.Costs of intravenous adverse drug events in academic nonacademic intensive care units[J].Med Care,2008,46(1):17-24.
[25] Grnberg B H,Sundstrm S,Kaasa S,et al.Influence of comorbidity on survival,toxicity and health-related quality of life in patients with advanced non-small-cell lung cancer receiving platinum-doublet chemotherapy[J].Europ J Cancer,2010,46(12):2225-2234.
[26] 盛小燕.广州市住院肿瘤化疗患者营养状况的现状调查及干预研究[D].广州:南方医科大学,2013.
[27] 杨桂英,吴颖,楚俊华.肿瘤患者化疗毒副反应的护理[J].齐齐哈尔医学院学报,2000,21(1):84-85.
[28] Morgan RM,Williams F,wright MM.An early warning scoring system for detecting developing critical illness[J].Chin Intensive Care,1997,8(2):100.
[29] Royal College of Physicians.National Early Warning Score(NEWS):Standardiz-ing the assessment of acute illness severity in the NHS(2012).[2018-03-13].[EB/OL].https://www.rcplondon.ac.uk/projects/outputs/national-early-warning-score-news.
[30] Agulnik A,Mora Robles L N,Forbes P W,et al.Improved outcomes after successful implementation of a pediatric early warning system (PEWS) in a resource-limited pediatric oncology hospital[J].Cancer,2017,123(15):2965-2974.
[31] Mooney K H,Beck S L,Friedman R H,et al.Automated monitoring of symptoms during ambulatory chemotherapy and oncology providers’use of the information:a randomized controlled clinical trial[J].Support Care Cancer,2014,22(9):2343-2350.
[32] Basch E,Deal A M,Kris M G,et al.Symptom Monitoring With Patient-Reported Outcomes During Routine Cancer Treatment:A Randomized Controlled Trial[J].J Clin Oncol,2016,34(6):557-565.
[33] Kearney N,Mccann L,Norrie J,et al.Evaluation of a mobile phone-based,advanced symptom management system(ASyMS)in the management of chemotherapy-related toxicity[J].Support Care Cancer,2009,17(4):437-444.
[34] 中国医院协会信息管理专业委员会.《中国医院信息化发展研究报告2008-2013(白皮书)》摘录[J].中国数字医学,2014,03(10):7-19.
[35] 刘婧英,李继平.护理信息系统应用效果分析研究现状[J].中华护理杂志,2014,49(06):729-731.
[36] 韩翠,葛宝兰,祖鹏婧.早期预警评分系统的应用现状分析[J].中国护理管理,2012,12(1):80-82.
[37] 孙晓敏,丁雅英,汪虹,等.住院患者护理风险评估预警监控传报系统的建立与应用效果评价[J].中国护理管理,2017,17(3):378-382.
[38] 朱琴,颜巧元.互联网用于老年患者延续护理的研究进展[J].中华护理杂志,2016,51(10):1221-1225.
[39] 方益波.癌症防治有了预警系统TAP检测进入临床应用[A].中华医学会微生物学与免疫学分会.第6次全国微生物学与免疫学大会论文摘要汇编[C].中华医学会微生物学与免疫学分会,2004:1.
[40] 田幂.基于概率SVM的肿瘤预警系统的设计与实现[D].长春:吉林大学,2013.
[41] 陆燕琼,陈秀云.化疗后Ⅳ度骨髓抑制的预警信号分析及护理[J].全科护理,2013,11(21):1945.
[42] 邓本敏,唐玲,皮远萍.肿瘤化疗消化道症状综合评分系统软件的临床应用[J].中国护理管理,2014,14(08):889-893.
[2] 郝希山.中国恶性肿瘤流行趋势及预防[C].第十三届中国科协年会第18分会场——癌症流行趋势和防控策略研究研讨会论文集.2011:10-11.
[3] 吴菲,林国桢,张晋昕.我国恶性肿瘤发病现状及趋势[J].中国肿瘤,2012,21(02):81-85.
[4] Torre L A,Bray F,Siegel R L,et al.Global cancer statistics,2012[J].CA:A Cancer J Clin,2015,65(2):87-108.
[5] Mcguire S.World Cancer Report 2014-Geneva,Switzerland:World Health Organization,International Agency for Research on Cancer,WHO Press,2015[J].Adv Nutr,2016,7(2):418-419.
[6] 陈万青,郑荣寿,张思维,等.2013年中国恶性肿瘤发病和死亡分析[J].中国肿瘤,2017,26(1):1-7.
[7] 中华人民共和国国家统计局.中国统计年鉴2016[M].北京:中国统计出版社,2016:1123-1124.
[8] 井明晰,于绍芬,段博识.肿瘤内科患者治疗中常见并发症的观察与处理对策[J].中国卫生产业,2012(14):162-162.
[9] Gupta V,Liu Y.New Insights on Glucosylceramide Synthase in Cancer Drug Resistance and Myelosuppression[J].Biochem Pharmacol,2013,2(03):120-123.
[10] Grnberg B H,Sundstrm S,Kaasa S,et al.Influence of comorbidity on survival,toxicity and health-related quality of life in patients with advanced non-small-cell lung cancer receiving platinum-doublet chemotherapy[J].Europ J Cancer,2010,46(12):2225-2234.
[11] Ballatori E,Roila F,Ruggeri B,et al.The impact of chemotherapy-induced nausea and vomiting on health-related quality of life.[J].Support Care Cancer,2007,15(2):179-185.
[12] Fujitani K,Ajani J A,Crane C H,et a1.Impact of induction chemothearpy and peropeartive chemoadriothearpy on opeartive morbidity and moartlity inpatients with loeoergional adencoacrinma of the stomach or gastroesphageal junction[J].Ann Surg Oncol,2007,14(7):2010-2017.
[13] Mrugank B P,Hareesha R P.Prospective Observational,Non-Randomized,Parallel Sequence study for assessment of Adverse Drug Reactions due to Chemo-therapeutic treatment in different types of Cancer patients[J].IJPSR,2013,4(1):386-391.
[14] 郑梦颖.化疗药物不良反应的临床表现及研究进展[D].重庆:重庆医科大学,2012.
[15] Chopra D,Rehan H S,Sharma V,et al.Chemotherapy-induced adverse drug reactions in oncology patients:A prospective observational survey[J].Indian J Med Paediatr Oncol,2016,37(1):42-46.
[16] 张阳,田丽,陈长英.化疗致脱发对癌症病人治疗依从性的影响及护理进展[J].护理研究,2017,31(29):3643-3646.
[17] Extermann M,Boler I,Reich RR,et al.Predicting the risk of chemotherapy toxicity in older patients:the Chemotherapy Risk Assessment Scale for High-Age Patients ( CRASH )score[J].Cancer,2012,118(13):3377-3386.
[18] Aapro M,Carides A,Rapoport BL,et al.Aprepitant and fosa-prepitant:A 10-year review of efficacy and safety[J].Oncologist,2015,20(4):450-458.
[19] Kearney N,Miller M,Maguire R,et al.WISECARE plus:Results of a European study of a nursing intervention for the management of chemotherapy-related symptoms[J].Eur J Oncol Nurs,2008,12(5):443-448.
[20] 王亚楠.新型抗肿瘤药物不良反应调查分析[D].济南:山东大学,2014.
[21] Lucas D,Scheiermann C,Chow A,et al.Chemotherapy-induced bone marrow nerve injury impairs hematopoietic regeneration[J].Nature Medicine,2013,19(6):695-703.
[22] 周婉,许勤,言克莉,等.消化道肿瘤化疗患者营养状况与生活质量及化疗不良反应的相关性分析[J].护理学报,2015,22(09):1-4.
[23] 王晓辉,朱珺,赵东.肺癌化疗不良反应的经济学研究[J].上海交通大学学报(医学版),2012,32(5):657-660.
[24] Nuckols TK,Paddock SM,Bower AG,et al.Costs of intravenous adverse drug events in academic nonacademic intensive care units[J].Med Care,2008,46(1):17-24.
[25] Grnberg B H,Sundstrm S,Kaasa S,et al.Influence of comorbidity on survival,toxicity and health-related quality of life in patients with advanced non-small-cell lung cancer receiving platinum-doublet chemotherapy[J].Europ J Cancer,2010,46(12):2225-2234.
[26] 盛小燕.广州市住院肿瘤化疗患者营养状况的现状调查及干预研究[D].广州:南方医科大学,2013.
[27] 杨桂英,吴颖,楚俊华.肿瘤患者化疗毒副反应的护理[J].齐齐哈尔医学院学报,2000,21(1):84-85.
[28] Morgan RM,Williams F,wright MM.An early warning scoring system for detecting developing critical illness[J].Chin Intensive Care,1997,8(2):100.
[29] Royal College of Physicians.National Early Warning Score(NEWS):Standardiz-ing the assessment of acute illness severity in the NHS(2012).[2018-03-13].[EB/OL].https://www.rcplondon.ac.uk/projects/outputs/national-early-warning-score-news.
[30] Agulnik A,Mora Robles L N,Forbes P W,et al.Improved outcomes after successful implementation of a pediatric early warning system (PEWS) in a resource-limited pediatric oncology hospital[J].Cancer,2017,123(15):2965-2974.
[31] Mooney K H,Beck S L,Friedman R H,et al.Automated monitoring of symptoms during ambulatory chemotherapy and oncology providers’use of the information:a randomized controlled clinical trial[J].Support Care Cancer,2014,22(9):2343-2350.
[32] Basch E,Deal A M,Kris M G,et al.Symptom Monitoring With Patient-Reported Outcomes During Routine Cancer Treatment:A Randomized Controlled Trial[J].J Clin Oncol,2016,34(6):557-565.
[33] Kearney N,Mccann L,Norrie J,et al.Evaluation of a mobile phone-based,advanced symptom management system(ASyMS)in the management of chemotherapy-related toxicity[J].Support Care Cancer,2009,17(4):437-444.
[34] 中国医院协会信息管理专业委员会.《中国医院信息化发展研究报告2008-2013(白皮书)》摘录[J].中国数字医学,2014,03(10):7-19.
[35] 刘婧英,李继平.护理信息系统应用效果分析研究现状[J].中华护理杂志,2014,49(06):729-731.
[36] 韩翠,葛宝兰,祖鹏婧.早期预警评分系统的应用现状分析[J].中国护理管理,2012,12(1):80-82.
[37] 孙晓敏,丁雅英,汪虹,等.住院患者护理风险评估预警监控传报系统的建立与应用效果评价[J].中国护理管理,2017,17(3):378-382.
[38] 朱琴,颜巧元.互联网用于老年患者延续护理的研究进展[J].中华护理杂志,2016,51(10):1221-1225.
[39] 方益波.癌症防治有了预警系统TAP检测进入临床应用[A].中华医学会微生物学与免疫学分会.第6次全国微生物学与免疫学大会论文摘要汇编[C].中华医学会微生物学与免疫学分会,2004:1.
[40] 田幂.基于概率SVM的肿瘤预警系统的设计与实现[D].长春:吉林大学,2013.
[41] 陆燕琼,陈秀云.化疗后Ⅳ度骨髓抑制的预警信号分析及护理[J].全科护理,2013,11(21):1945.
[42] 邓本敏,唐玲,皮远萍.肿瘤化疗消化道症状综合评分系统软件的临床应用[J].中国护理管理,2014,14(08):889-893.